<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's diseaseAlfredo Berardelli, M Vidailhet, Gregor K. Wenning et al.|European Journal of Neurology|2012Cited by 490
Trial of Deferiprone in Parkinson’s DiseaseDavid Devos, Christoph Scherfler, Petr Dušek et al.|New England Journal of Medicine|2022Cited by 226
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive TherapiesGünther Deuschl, Elena Moro, Angelo Antonini et al.|Movement Disorders|2022Cited by 178
European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapiesGünther Deuschl, Elena Moro, Angelo Antonini et al.|European Journal of Neurology|2022Cited by 106
Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?Martina Hoskovcová, Evžen Růžička|PLoS ONE|2015Cited by 54